Paul Tudor Jones's CRL Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 4,782 shares of Charles River Laboratories International, Inc. (CRL) worth $953,913, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in CRL, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2016, adding 244,223 shares. Largest reduction occurred in Q3 2016, reducing 153,937 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -87,935 | Reduce 94.84% | 4,782 | $199.48 |
| Q3 2025 | -77,077 | Reduce 45.39% | 92,717 | $156.46 |
| Q2 2025 | +100,669 | Add 145.63% | 169,794 | $151.73 |
| Q1 2025 | +12,839 | Add 22.81% | 69,125 | $150.52 |
| Q4 2024 | +56,286 | New Buy | 56,286 | $184.60 |
| Q3 2024 | -18,998 | Sold Out | 0 | $0.00 |
| Q2 2024 | -1,697 | Reduce 8.20% | 18,998 | $206.58 |
| Q1 2024 | -45,222 | Reduce 68.60% | 20,695 | $270.95 |
| Q4 2023 | +8,744 | Add 15.29% | 65,917 | $236.40 |
| Q3 2023 | +57,173 | New Buy | 57,173 | $195.98 |
| Q3 2022 | -16,193 | Sold Out | 0 | $0.00 |
| Q2 2022 | +3,727 | Add 29.90% | 16,193 | $213.98 |
| Q1 2022 | +1,075 | Add 9.44% | 12,466 | $283.97 |
| Q4 2021 | +11,391 | New Buy | 11,391 | $376.79 |
| Q3 2021 | -3,368 | Sold Out | 0 | $0.00 |
| Q2 2021 | -10,418 | Reduce 75.57% | 3,368 | $369.95 |
| Q1 2021 | +4,934 | Add 55.74% | 13,786 | $289.86 |
| Q4 2020 | +8,852 | New Buy | 8,852 | $249.89 |
| Q2 2020 | -3,572 | Sold Out | 0 | $0.00 |
| Q1 2020 | +1,045 | Add 41.35% | 3,572 | $126.26 |
| Q4 2019 | -2,663 | Reduce 51.31% | 2,527 | $152.75 |
| Q3 2019 | +5,190 | New Buy | 5,190 | $132.37 |
| Q3 2017 | -6,310 | Sold Out | 0 | $0.00 |
| Q2 2017 | -4,914 | Reduce 43.78% | 6,310 | $101.11 |
| Q1 2017 | +2,704 | Add 31.74% | 11,224 | $89.99 |
| Q4 2016 | -380 | Reduce 4.27% | 8,520 | $76.17 |
| Q3 2016 | -153,937 | Reduce 94.53% | 8,900 | $83.37 |
| Q2 2016 | -101,722 | Reduce 38.45% | 162,837 | $82.44 |
| Q1 2016 | +244,223 | Add 1200.94% | 264,559 | $75.94 |
| Q4 2015 | +4,267 | Add 26.55% | 20,336 | $80.40 |
| Q3 2015 | +7,215 | Add 81.49% | 16,069 | $63.54 |
| Q2 2015 | -1,268 | Reduce 12.53% | 8,854 | $70.36 |
| Q1 2015 | +1,422 | Add 16.34% | 10,122 | $79.33 |
| Q4 2014 | -3,100 | Reduce 26.27% | 8,700 | $63.68 |
| Q3 2014 | -6,294 | Reduce 34.79% | 11,800 | $59.75 |
| Q2 2014 | +1,333 | Add 7.95% | 18,094 | $53.50 |
| Q1 2014 | +7,461 | Add 80.23% | 16,761 | $60.32 |
| Q4 2013 | +600 | Add 6.90% | 9,300 | $53.01 |
| Q3 2013 | -900 | Reduce 9.38% | 8,700 | $46.21 |
| Q2 2013 | +9,600 | Add 0.00% | 9,600 | $41.04 |
Paul Tudor Jones's Charles River Laboratories International Investment FAQs
Paul Tudor Jones first purchased Charles River Laboratories International, Inc. (CRL) in Q2 2013, acquiring 9,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Charles River Laboratories International, Inc. (CRL) for 40 quarters since Q2 2013.
Paul Tudor Jones's largest addition to Charles River Laboratories International, Inc. (CRL) was in Q1 2016, adding 264,559 shares worth $20.09 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 4,782 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $953,913.
As of the Q4 2025 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Charles River Laboratories International, Inc. (CRL) was 264,559 shares, as reported at the end of Q1 2016.